Literature DB >> 12837738

European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria.

Gunnar Kahlmeter1, Derek F J Brown, Fred W Goldstein, Alasdair P MacGowan, Johan W Mouton, Anders Osterlund, Arne Rodloff, Martin Steinbakk, Pavla Urbaskova, Alkiviadis Vatopoulos.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12837738     DOI： 10.1093/jac/dkg312

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  93 in total

1.  Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC, and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica.

Authors:  Deborah J Eaves; Luke Randall; Douglas T Gray; Antony Buckley; Martin J Woodward; Allan P White; Laura J V Piddock
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

2.  Designing fluoroquinolone breakpoints for Streptococcus pneumoniae by using genetics instead of pharmacokinetics-pharmacodynamics.

Authors:  H J Smith; A M Noreddin; C G Siemens; K N Schurek; J Greisman; C J Hoban; D J Hoban; G G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

3.  Use of Monte Carlo simulations to select therapeutic doses and provisional breakpoints of BAL9141.

Authors:  Johan W Mouton; Anne Schmitt-Hoffmann; Stuart Shapiro; Norman Nashed; Nieko C Punt
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

Review 4.  Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012.

Authors:  M A Pfaller; D J Diekema
Journal:  J Clin Microbiol       Date:  2012-06-27       Impact factor: 5.948

5.  Intra- and interlaboratory performances of two commercial antimicrobial susceptibility testing methods for bifidobacteria and nonenterococcal lactic acid bacteria.

Authors:  Geert Huys; Klaas D'Haene; Margo Cnockaert; Lorenzo Tosi; Morten Danielsen; Ana Belén Flórez; Jaana Mättö; Lars Axelsson; Jenni Korhonen; Sigrid Mayrhofer; Maria Egervärn; Mauro Giacomini; Peter Vandamme
Journal:  Antimicrob Agents Chemother       Date:  2010-04-12       Impact factor: 5.191

6.  Normalized resistance interpretation as a tool for establishing epidemiological MIC susceptibility breakpoints.

Authors:  Göran Kronvall
Journal:  J Clin Microbiol       Date:  2010-10-06       Impact factor: 5.948

Review 7.  [Strategies for antifungal treatment failure in intensive care units].

Authors:  C Arens; M Bernhard; C Koch; A Heininger; D Störzinger; T Hoppe-Tichy; M Hecker; B Grabein; M A Weigand; C Lichtenstern
Journal:  Anaesthesist       Date:  2015-09       Impact factor: 1.041

8.  Antibiotic Resistance in Young Children in Kilosa District, Tanzania 4 Years after Mass Distribution of Azithromycin for Trachoma Control.

Authors:  Evan M Bloch; Sheila K West; Kasubi Mabula; Jerusha Weaver; Zakayo Mrango; Beatriz Munoz; Thomas Lietman; Christian Coles
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

9.  Effect of differences in MIC values on clinical outcomes in patients with bloodstream infections caused by gram-negative organisms treated with levofloxacin.

Authors:  Robyn Defife; Marc H Scheetz; Joe M Feinglass; Michael J Postelnick; Kimberly K Scarsi
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

10.  A statistical approach for determination of disk diffusion-based cutoff values for systematic characterization of wild-type and non-wild-type bacterial populations in antimicrobial susceptibility testing.

Authors:  Giorgia Valsesia; Malgorzata Roos; Erik C Böttger; Michael Hombach
Journal:  J Clin Microbiol       Date:  2015-03-11       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.